Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Decreases Aspergillaceae - : voriconazole,(prescription) |
👪
In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue Pages: 936814 Pub: 2022 Epub: 2022 Jul 5 Authors Jiang H , Xiong J , Tan L , Jin P , Sun Y , Yang L , Tan J , Html Article Publication |
Decreases Aspergillaceae - : voriconazole,(prescription) |
👪
In vitro interactions of proton pump inhibitors and azoles against pathogenic fungi. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 14 Issue Pages: 1296151 Pub: 2024 Epub: 2024 Jan 17 Authors Gao L , Xia X , Gong X , Zhang H , Sun Y , Html Article Publication |
Decreases Aspergillaceae - : voriconazole,(prescription) |
👪
Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China. Frontiers in public health (Front Public Health ) Vol: 11 Issue Pages: 1292162 Pub: 2023 Epub: 2023 Dec 19 Authors Han G , Xu Q , Lv Q , Li X , Shi X , Html Article Publication |
Decreases Aspergillaceae - : voriconazole,(prescription) |
👪
Comparison of the Micronaut-AM System and the EUCAST Broth Microdilution Reference Method for MIC Determination of Four Antifungals against Aspergillus fumigatus. Journal of fungi (Basel, Switzerland) (J Fungi (Basel) ) Vol: 9 Issue 7 Pages: Pub: 2023 Jun 30 Epub: 2023 Jun 30 Authors Gyurtane Szabo N , Joste V , Houzé S , Dannaoui E , Bonnal C , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]